Evidence map›Paper›PMID 37064314›Full record

ArticleHealth science reports2023

Investigating the performance of machine learning algorithms in predicting the survival of COVID-19 patients: A cross section study of Iran.

Azita Yazdani, Somayeh Kianian Bigdeli, Maryam Zahmatkeshan

Abstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Azita YazdaniDepartment of Health Information Management, School of Health Management and Information Sciences Shiraz University of Medical Sciences Shiraz Iran.ORCID 0000-0002-5190-286X
Somayeh Kianian BigdeliHealth Information Management Department, School of Allied Medical Sciences Tehran University of Medical Sciences Tehran Iran.ORCID 0009-0008-0278-3033
Maryam ZahmatkeshanNoncommunicable Diseases Research Center Fasa University of Medical Sciences Fasa Iran.ORCID 0000-0003-4090-391X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Like early diagnosis, predicting the survival of patients with Coronavirus Disease 2019 (COVID-19) is of great importance. Survival prediction models help doctors be more cautious to treat the patients who are at high risk of dying because of medical conditions. This study aims to predict the survival of hospitalized patients with COVID-19 by comparing the accuracy of machine learning (ML) models. Methods: It is a cross-sectional study which was performed in 2022 in Fasa city in Iran country. The research data set was extracted from the period February 18, 2020 to February 10, 2021, and contains 2442 hospitalized patients' records with 84 features. A comparison was made between the efficiency of five ML algorithms to predict survival, includes Naive Bayes (NB), K-nearest neighbors (KNN), random forest (RF), decision tree (DT), and multilayer perceptron (MLP). Modeling steps were done with Python language in the Anaconda Navigator 3 environment. Results: Our findings show that NB algorithm had better performance than others with accuracy, precision, recall, F-score, and area under receiver operating characteristic curve of 97%, 96%, 96%, 96%, and 97%, respectively. Based on the analysis of factors affecting survival, heart disease, pulmonary diseases and blood related disease were the most important disease related to death. Conclusion: The development of software systems based on NB will be effective to predict the survival of COVID-19 patients.

Indexed as

COVID‐19decision treeK‐nearest neighborsmachine learningNaive Bayesrandom forest

Identifiers

PMID37064314
PMCPMC10099201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.